NCLEX RN Practice Question

The primary purpose of administering Rh immunoglobulin (RhoGAM) to an Rh-negative pregnant client is to prevent the development of Rh antibodies in the mother. Without this intervention, maternal exposure to fetal Rh-positive blood could lead to the formation of antibodies that may attack the red blood cells of Rh-positive fetuses in subsequent pregnancies, potentially leading to hemolytic disease of the newborn. It is not used to treat anemia, protect against infections, or prevent maternal blood clot formation, as these are unrelated to its function.